The U.S. Food and Drug Administration should continue to exercise regulatory discretion to maintain the continued availability of a number of unapproved animal drug products, said the National Grain and Feed Association in a statement to the FDA.
The types of animal feed and pet food products currently regulated by the FDA that could fall within the category of “unapproved animal drugs” include products formulated from animal feed ingredients that help manage, from a dietary and nutritional standpoint, a specific disease or condition under a licensed veterinarian’s professional supervision, said the NGFA. These products are “generally recognized as safe” or have been authorized under food additive petitions, and have a long history of safe and effective use.
According to the NGFA, pertinent examples of such products include:
The FDA put out a request for comments soliciting suggestions for strategies to address the prevalence of animal drug products marketed within the U.S. without approval or other legal marketing status. The agency has said that it is concerned that the safety and effectiveness of some unapproved animal drugs being marketed have not been demonstrated properly, but also recognizes that the continued availability of a number of such products is important to meet the health needs of animals.
The FDA is looking for comments on approaches that utilize its existing regulatory framework for increasing the number of currently marketed animal drugs that have legal marketing status, as well as the use of enforcement discretion in limited situations, said the agency.
The American Feed Industry Association (AFIA) has filed comments to the U.S. Food and Drug Administration (FDA) on the removal of trans fats from America’s food system. Although AFIA has no opinion on FDA’s proposal to phase out partially hydrogenated oils (PHOs) from the “generally recognized as safe” (GRAS) category for human consumption, the organization expressed concern that FDA does not clearly define that the phaseout process only applies to human food for consumption and not animal food.
Desired deadline is June 30
Brad Frisvold promoted to role for Americas region
CFIA’s study into cause of disease will continue
Brazilian study finds selenium, vitamin E lead to lower cholesterol
Syncra AVI, from Danisco Animal Nutrition, is a solution designed to
fully unlock healthy nutrition benefits from animal
feed. Xylanase, amylase, protease and multi-strain Bacillus are combined
to better break down protein, increase digestibility, decrease
bacterial levels, and release previously trapped nutrients.
Transaction includes feed product line
--- Thank you for your patience ----
If you have any issues logging in or any other need feel free to contact us.